CLINICAL_TRIALS
withdrawal
· 2026-03-03
Clinical Trial Update: Extended Oral Tranexamic Acid After Anterior Cruciate Ligament Reconstruction [Phase 4]
Summary
The Phase 4 trial evaluating extended oral tranexamic acid after anterior cruciate ligament reconstruction has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Campbell Clinic | Conditions: ACL Injury, ACL Tears | Phase 4 | Status: WITHDRAWN